FTC and NY sue Daraprim maker over access to samples

Ben Remaly

28 January 2020

The Federal Trade Commission and state of New York have alleged that Vyera Pharmaceuticals broke federal antitrust laws by denying access to samples that competitors needed to replicate its infection-treating drug.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Ben Remaly

View full biography

Author | Editor, GCR USA

[email protected]

Tipline

Hiding in plain sight: The Tipline for 20 September 2023
George Mason Law graduates Elyse Dorsey and Angela Landry said on Tuesday that Joshua Wright’s defamation lawsuit violates Virginia law because it was written to punish them for accusing him of sexual misconduct. In addition to asking the local court to have Wright cover their legal fees, Dorsey says she could not have harmed Wright’s reputation by repeating an “open secret”. Speaking of open secrets, Judge Amit Mehta has asked the Department of Justice …
Field of Dreams: The Tipline for 19 September 2023
Chip and a chair: The Tipline for 18 September 2023